Retatrutide is an investigational triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, enhancing insulin secretion, suppressing appetite, increasing energy expenditure, and promoting hepatic fat oxidation
Pharmacol Ther 113: 546-593, 2007
Staying at the minimum effective dose rather than automatically escalating to the highest saves significant peptide over time
For GLP-1s, it costs $129 for the first month ($80 off), then $209 per month
Experts agree removing GLP-1s from the 503B bulks list will significantly lower the availability of compounded GLP-1s drugs
Bulk procurement can improve inventory planning, simplify ordering processes, and create greater supply consistency for organizations managing multiple projects